Bausch Health sets 2025 outlook at the higher end of the prior range
Source: SeekingAlpha
2026-01-13 10:54:37 ET
More on Bausch Health Companies
- Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path
- Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results
- Carl Icahn's top Q3 moves include new stake in EchoStar, exiting Bausch Health
- Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth
Read the full article on Seeking Alpha
For further details see:
Bausch Health sets 2025 outlook at the higher end of the prior range
Bausch Health Companies Inc.
NASDAQ: BHC:CC
BHC:CC Trading
-0.34% G/L:
$5.88 Last:
1,784,767 Volume:
$5.90 Open:
BHC:CC Latest News
February 23, 2026 08:00:00 am
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 19, 2026 08:00:00 am
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
